CAMBRIDGE, Mass.--(BUSINESS WIRE)--
- Michael J. Pellini, M.D., president and chief executive officer, will present at the Goldman Sachs Global Healthcare Conference on Wednesday, June 11, 2014 at 4:00 p.m. P.T. in Rancho Palos Verdes, CA.
- Steven J. Kafka, Ph.D., chief operating officer, will present at the JMP Securities Healthcare Conference on Tuesday, June 24, 2014 at 3:00 p.m. E.T. in New York, NY.
Live, listen-only webcasts of the presentations may be accessed by visiting the investors section of the company’s website at investors.foundationmedicine.com. A replay of each webcast will be available shortly after the conclusion of the presentation and will be archived on the company's website for two weeks following each presentation.
About Foundation Medicine
Foundation Medicine (FMI) is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company's clinical assays, FoundationOne for solid tumors and FoundationOne Heme for hematologic malignancies, sarcomas and pediatric cancers, provide a fully informative genomic profile to identify the molecular alterations in a patient's cancer and match them with relevant targeted therapies and clinical trials. Foundation Medicine's molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. For more information, please visit www.FoundationMedicine.com or follow Foundation Medicine on Twitter (@FoundationATCG).
Foundation Medicine® and FoundationOne® are registered trademarks of Foundation Medicine, Inc.
- Health Care Industry